Pharmaceutical Contract Development and Manufacturing-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Pharmaceutical Contract Development and Manufacturing-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Pharmaceutical Contract Development and Manufacturing industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Pharmaceutical Contract Development and Manufacturing 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pharmaceutical Contract Development and Manufacturing worldwide and market share by regions, with company and product introduction, position in the Pharmaceutical Contract Development and Manufacturing market
Market status and development trend of Pharmaceutical Contract Development and Manufacturing by types and applications
Cost and profit status of Pharmaceutical Contract Development and Manufacturing, and marketing status
Market growth drivers and challenges
The report segments the global Pharmaceutical Contract Development and Manufacturing market as:
Global Pharmaceutical Contract Development and Manufacturing Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Pharmaceutical Contract Development and Manufacturing Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Global Pharmaceutical Contract Development and Manufacturing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Big Pharma
Small Pharma
Generic Pharma
CRO
Global Pharmaceutical Contract Development and Manufacturing Market: Manufacturers Segment Analysis (Company and Product introduction, Pharmaceutical Contract Development and Manufacturing Sales Volume, Revenue, Price and Gross Margin):
AbbVie Inc.
Aenova Group
Recipharm AB
Catalent, Inc.
Thermo Fisher Scientific Inc.
Lonza Group Ltd
Almac Group
FAMAR Health Care Services
Vetter Pharma International GMBH
Consort Medical plc
Siegfried Holding AG
Boehringer Ingelheim International GmbH
Evonik Industries AG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pharmaceutical Contract Development and Manufacturing-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Pharmaceutical Contract Development and Manufacturing industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Pharmaceutical Contract Development and Manufacturing 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pharmaceutical Contract Development and Manufacturing worldwide and market share by regions, with company and product introduction, position in the Pharmaceutical Contract Development and Manufacturing market
Market status and development trend of Pharmaceutical Contract Development and Manufacturing by types and applications
Cost and profit status of Pharmaceutical Contract Development and Manufacturing, and marketing status
Market growth drivers and challenges
The report segments the global Pharmaceutical Contract Development and Manufacturing market as:
Global Pharmaceutical Contract Development and Manufacturing Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Pharmaceutical Contract Development and Manufacturing Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Global Pharmaceutical Contract Development and Manufacturing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Big Pharma
Small Pharma
Generic Pharma
CRO
Global Pharmaceutical Contract Development and Manufacturing Market: Manufacturers Segment Analysis (Company and Product introduction, Pharmaceutical Contract Development and Manufacturing Sales Volume, Revenue, Price and Gross Margin):
AbbVie Inc.
Aenova Group
Recipharm AB
Catalent, Inc.
Thermo Fisher Scientific Inc.
Lonza Group Ltd
Almac Group
FAMAR Health Care Services
Vetter Pharma International GMBH
Consort Medical plc
Siegfried Holding AG
Boehringer Ingelheim International GmbH
Evonik Industries AG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
1.1 Definition of Pharmaceutical Contract Development and Manufacturing in This Report
1.2 Commercial Types of Pharmaceutical Contract Development and Manufacturing
1.2.1 Pharmaceutical Manufacturing Services
1.2.2 Biologics Manufacturing Services
1.2.3 Drug Development Services
1.3 Downstream Application of Pharmaceutical Contract Development and Manufacturing
1.3.1 Big Pharma
1.3.2 Small Pharma
1.3.3 Generic Pharma
1.3.4 CRO
1.4 Development History of Pharmaceutical Contract Development and Manufacturing
1.5 Market Status and Trend of Pharmaceutical Contract Development and Manufacturing 2013-2023
1.5.1 Global Pharmaceutical Contract Development and Manufacturing Market Status and Trend 2013-2023
1.5.2 Regional Pharmaceutical Contract Development and Manufacturing Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pharmaceutical Contract Development and Manufacturing 2013-2017
2.2 Sales Market of Pharmaceutical Contract Development and Manufacturing by Regions
2.2.1 Sales Volume of Pharmaceutical Contract Development and Manufacturing by Regions
2.2.2 Sales Value of Pharmaceutical Contract Development and Manufacturing by Regions
2.3 Production Market of Pharmaceutical Contract Development and Manufacturing by Regions
2.4 Global Market Forecast of Pharmaceutical Contract Development and Manufacturing 2018-2023
2.4.1 Global Market Forecast of Pharmaceutical Contract Development and Manufacturing 2018-2023
2.4.2 Market Forecast of Pharmaceutical Contract Development and Manufacturing by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pharmaceutical Contract Development and Manufacturing by Types
3.2 Sales Value of Pharmaceutical Contract Development and Manufacturing by Types
3.3 Market Forecast of Pharmaceutical Contract Development and Manufacturing by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pharmaceutical Contract Development and Manufacturing by Downstream Industry
4.2 Global Market Forecast of Pharmaceutical Contract Development and Manufacturing by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pharmaceutical Contract Development and Manufacturing Market Status by Countries
5.1.1 North America Pharmaceutical Contract Development and Manufacturing Sales by Countries (2013-2017)
5.1.2 North America Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2013-2017)
5.1.3 United States Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
5.1.4 Canada Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
5.1.5 Mexico Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
5.2 North America Pharmaceutical Contract Development and Manufacturing Market Status by Manufacturers
5.3 North America Pharmaceutical Contract Development and Manufacturing Market Status by Type (2013-2017)
5.3.1 North America Pharmaceutical Contract Development and Manufacturing Sales by Type (2013-2017)
5.3.2 North America Pharmaceutical Contract Development and Manufacturing Revenue by Type (2013-2017)
5.4 North America Pharmaceutical Contract Development and Manufacturing Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pharmaceutical Contract Development and Manufacturing Market Status by Countries
6.1.1 Europe Pharmaceutical Contract Development and Manufacturing Sales by Countries (2013-2017)
6.1.2 Europe Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2013-2017)
6.1.3 Germany Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.4 UK Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.5 France Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.6 Italy Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.7 Russia Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.8 Spain Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.9 Benelux Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.2 Europe Pharmaceutical Contract Development and Manufacturing Market Status by Manufacturers
6.3 Europe Pharmaceutical Contract Development and Manufacturing Market Status by Type (2013-2017)
6.3.1 Europe Pharmaceutical Contract Development and Manufacturing Sales by Type (2013-2017)
6.3.2 Europe Pharmaceutical Contract Development and Manufacturing Revenue by Type (2013-2017)
6.4 Europe Pharmaceutical Contract Development and Manufacturing Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pharmaceutical Contract Development and Manufacturing Market Status by Countries
7.1.1 Asia Pacific Pharmaceutical Contract Development and Manufacturing Sales by Countries (2013-2017)
7.1.2 Asia Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2013-2017)
7.1.3 China Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
7.1.4 Japan Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
7.1.5 India Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
7.1.6 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
7.1.7 Australia Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
7.2 Asia Pacific Pharmaceutical Contract Development and Manufacturing Market Status by Manufacturers
7.3 Asia Pacific Pharmaceutical Contract Development and Manufacturing Market Status by Type (2013-2017)
7.3.1 Asia Pacific Pharmaceutical Contract Development and Manufacturing Sales by Type (2013-2017)
7.3.2 Asia Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Type (2013-2017)
7.4 Asia Pacific Pharmaceutical Contract Development and Manufacturing Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pharmaceutical Contract Development and Manufacturing Market Status by Countries
8.1.1 Latin America Pharmaceutical Contract Development and Manufacturing Sales by Countries (2013-2017)
8.1.2 Latin America Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2013-2017)
8.1.3 Brazil Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
8.1.4 Argentina Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
8.1.5 Colombia Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
8.2 Latin America Pharmaceutical Contract Development and Manufacturing Market Status by Manufacturers
8.3 Latin America Pharmaceutical Contract Development and Manufacturing Market Status by Type (2013-2017)
8.3.1 Latin America Pharmaceutical Contract Development and Manufacturing Sales by Type (2013-2017)
8.3.2 Latin America Pharmaceutical Contract Development and Manufacturing Revenue by Type (2013-2017)
8.4 Latin America Pharmaceutical Contract Development and Manufacturing Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Market Status by Countries
9.1.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2013-2017)
9.1.3 Middle East Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
9.1.4 Africa Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
9.2 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Market Status by Manufacturers
9.3 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Sales by Type (2013-2017)
9.3.2 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue by Type (2013-2017)
9.4 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
10.1 Global Economy Situation and Trend Overview
10.2 Pharmaceutical Contract Development and Manufacturing Downstream Industry Situation and Trend Overview
CHAPTER 11 PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
11.2 Production Value of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
11.3 Basic Information of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pharmaceutical Contract Development and Manufacturing Major Manufacturer
11.3.2 Employees and Revenue Level of Pharmaceutical Contract Development and Manufacturing Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 AbbVie Inc.
12.1.1 Company profile
12.1.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.1.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of AbbVie Inc.
12.2 Aenova Group
12.2.1 Company profile
12.2.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.2.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Aenova Group
12.3 Recipharm AB
12.3.1 Company profile
12.3.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.3.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Recipharm AB
12.4 Catalent, Inc.
12.4.1 Company profile
12.4.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.4.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Catalent, Inc.
12.5 Thermo Fisher Scientific Inc.
12.5.1 Company profile
12.5.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.5.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific Inc.
12.6 Lonza Group Ltd
12.6.1 Company profile
12.6.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.6.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Lonza Group Ltd
12.7 Almac Group
12.7.1 Company profile
12.7.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.7.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Almac Group
12.8 FAMAR Health Care Services
12.8.1 Company profile
12.8.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.8.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of FAMAR Health Care Services
12.9 Vetter Pharma International GMBH
12.9.1 Company profile
12.9.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.9.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Vetter Pharma International GMBH
12.10 Consort Medical plc
12.10.1 Company profile
12.10.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.10.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Consort Medical plc
12.11 Siegfried Holding AG
12.11.1 Company profile
12.11.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.11.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Siegfried Holding AG
12.12 Boehringer Ingelheim International GmbH
12.12.1 Company profile
12.12.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.12.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim International GmbH
12.13 Evonik Industries AG
12.13.1 Company profile
12.13.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.13.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Evonik Industries AG
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
13.1 Industry Chain of Pharmaceutical Contract Development and Manufacturing
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
14.1 Cost Structure Analysis of Pharmaceutical Contract Development and Manufacturing
14.2 Raw Materials Cost Analysis of Pharmaceutical Contract Development and Manufacturing
14.3 Labor Cost Analysis of Pharmaceutical Contract Development and Manufacturing
14.4 Manufacturing Expenses Analysis of Pharmaceutical Contract Development and Manufacturing
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Pharmaceutical Contract Development and Manufacturing in This Report
1.2 Commercial Types of Pharmaceutical Contract Development and Manufacturing
1.2.1 Pharmaceutical Manufacturing Services
1.2.2 Biologics Manufacturing Services
1.2.3 Drug Development Services
1.3 Downstream Application of Pharmaceutical Contract Development and Manufacturing
1.3.1 Big Pharma
1.3.2 Small Pharma
1.3.3 Generic Pharma
1.3.4 CRO
1.4 Development History of Pharmaceutical Contract Development and Manufacturing
1.5 Market Status and Trend of Pharmaceutical Contract Development and Manufacturing 2013-2023
1.5.1 Global Pharmaceutical Contract Development and Manufacturing Market Status and Trend 2013-2023
1.5.2 Regional Pharmaceutical Contract Development and Manufacturing Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pharmaceutical Contract Development and Manufacturing 2013-2017
2.2 Sales Market of Pharmaceutical Contract Development and Manufacturing by Regions
2.2.1 Sales Volume of Pharmaceutical Contract Development and Manufacturing by Regions
2.2.2 Sales Value of Pharmaceutical Contract Development and Manufacturing by Regions
2.3 Production Market of Pharmaceutical Contract Development and Manufacturing by Regions
2.4 Global Market Forecast of Pharmaceutical Contract Development and Manufacturing 2018-2023
2.4.1 Global Market Forecast of Pharmaceutical Contract Development and Manufacturing 2018-2023
2.4.2 Market Forecast of Pharmaceutical Contract Development and Manufacturing by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pharmaceutical Contract Development and Manufacturing by Types
3.2 Sales Value of Pharmaceutical Contract Development and Manufacturing by Types
3.3 Market Forecast of Pharmaceutical Contract Development and Manufacturing by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pharmaceutical Contract Development and Manufacturing by Downstream Industry
4.2 Global Market Forecast of Pharmaceutical Contract Development and Manufacturing by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pharmaceutical Contract Development and Manufacturing Market Status by Countries
5.1.1 North America Pharmaceutical Contract Development and Manufacturing Sales by Countries (2013-2017)
5.1.2 North America Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2013-2017)
5.1.3 United States Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
5.1.4 Canada Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
5.1.5 Mexico Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
5.2 North America Pharmaceutical Contract Development and Manufacturing Market Status by Manufacturers
5.3 North America Pharmaceutical Contract Development and Manufacturing Market Status by Type (2013-2017)
5.3.1 North America Pharmaceutical Contract Development and Manufacturing Sales by Type (2013-2017)
5.3.2 North America Pharmaceutical Contract Development and Manufacturing Revenue by Type (2013-2017)
5.4 North America Pharmaceutical Contract Development and Manufacturing Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pharmaceutical Contract Development and Manufacturing Market Status by Countries
6.1.1 Europe Pharmaceutical Contract Development and Manufacturing Sales by Countries (2013-2017)
6.1.2 Europe Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2013-2017)
6.1.3 Germany Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.4 UK Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.5 France Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.6 Italy Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.7 Russia Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.8 Spain Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.1.9 Benelux Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
6.2 Europe Pharmaceutical Contract Development and Manufacturing Market Status by Manufacturers
6.3 Europe Pharmaceutical Contract Development and Manufacturing Market Status by Type (2013-2017)
6.3.1 Europe Pharmaceutical Contract Development and Manufacturing Sales by Type (2013-2017)
6.3.2 Europe Pharmaceutical Contract Development and Manufacturing Revenue by Type (2013-2017)
6.4 Europe Pharmaceutical Contract Development and Manufacturing Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pharmaceutical Contract Development and Manufacturing Market Status by Countries
7.1.1 Asia Pacific Pharmaceutical Contract Development and Manufacturing Sales by Countries (2013-2017)
7.1.2 Asia Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2013-2017)
7.1.3 China Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
7.1.4 Japan Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
7.1.5 India Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
7.1.6 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
7.1.7 Australia Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
7.2 Asia Pacific Pharmaceutical Contract Development and Manufacturing Market Status by Manufacturers
7.3 Asia Pacific Pharmaceutical Contract Development and Manufacturing Market Status by Type (2013-2017)
7.3.1 Asia Pacific Pharmaceutical Contract Development and Manufacturing Sales by Type (2013-2017)
7.3.2 Asia Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Type (2013-2017)
7.4 Asia Pacific Pharmaceutical Contract Development and Manufacturing Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pharmaceutical Contract Development and Manufacturing Market Status by Countries
8.1.1 Latin America Pharmaceutical Contract Development and Manufacturing Sales by Countries (2013-2017)
8.1.2 Latin America Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2013-2017)
8.1.3 Brazil Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
8.1.4 Argentina Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
8.1.5 Colombia Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
8.2 Latin America Pharmaceutical Contract Development and Manufacturing Market Status by Manufacturers
8.3 Latin America Pharmaceutical Contract Development and Manufacturing Market Status by Type (2013-2017)
8.3.1 Latin America Pharmaceutical Contract Development and Manufacturing Sales by Type (2013-2017)
8.3.2 Latin America Pharmaceutical Contract Development and Manufacturing Revenue by Type (2013-2017)
8.4 Latin America Pharmaceutical Contract Development and Manufacturing Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Market Status by Countries
9.1.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2013-2017)
9.1.3 Middle East Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
9.1.4 Africa Pharmaceutical Contract Development and Manufacturing Market Status (2013-2017)
9.2 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Market Status by Manufacturers
9.3 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Sales by Type (2013-2017)
9.3.2 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue by Type (2013-2017)
9.4 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
10.1 Global Economy Situation and Trend Overview
10.2 Pharmaceutical Contract Development and Manufacturing Downstream Industry Situation and Trend Overview
CHAPTER 11 PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
11.2 Production Value of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
11.3 Basic Information of Pharmaceutical Contract Development and Manufacturing by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pharmaceutical Contract Development and Manufacturing Major Manufacturer
11.3.2 Employees and Revenue Level of Pharmaceutical Contract Development and Manufacturing Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 AbbVie Inc.
12.1.1 Company profile
12.1.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.1.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of AbbVie Inc.
12.2 Aenova Group
12.2.1 Company profile
12.2.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.2.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Aenova Group
12.3 Recipharm AB
12.3.1 Company profile
12.3.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.3.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Recipharm AB
12.4 Catalent, Inc.
12.4.1 Company profile
12.4.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.4.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Catalent, Inc.
12.5 Thermo Fisher Scientific Inc.
12.5.1 Company profile
12.5.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.5.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific Inc.
12.6 Lonza Group Ltd
12.6.1 Company profile
12.6.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.6.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Lonza Group Ltd
12.7 Almac Group
12.7.1 Company profile
12.7.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.7.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Almac Group
12.8 FAMAR Health Care Services
12.8.1 Company profile
12.8.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.8.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of FAMAR Health Care Services
12.9 Vetter Pharma International GMBH
12.9.1 Company profile
12.9.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.9.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Vetter Pharma International GMBH
12.10 Consort Medical plc
12.10.1 Company profile
12.10.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.10.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Consort Medical plc
12.11 Siegfried Holding AG
12.11.1 Company profile
12.11.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.11.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Siegfried Holding AG
12.12 Boehringer Ingelheim International GmbH
12.12.1 Company profile
12.12.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.12.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim International GmbH
12.13 Evonik Industries AG
12.13.1 Company profile
12.13.2 Representative Pharmaceutical Contract Development and Manufacturing Product
12.13.3 Pharmaceutical Contract Development and Manufacturing Sales, Revenue, Price and Gross Margin of Evonik Industries AG
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
13.1 Industry Chain of Pharmaceutical Contract Development and Manufacturing
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING
14.1 Cost Structure Analysis of Pharmaceutical Contract Development and Manufacturing
14.2 Raw Materials Cost Analysis of Pharmaceutical Contract Development and Manufacturing
14.3 Labor Cost Analysis of Pharmaceutical Contract Development and Manufacturing
14.4 Manufacturing Expenses Analysis of Pharmaceutical Contract Development and Manufacturing
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
